# EDGAR Filing Document

**Accession Number:** 0001051514
**File Stem:** 0001213900-26-021556
**Filing Date:** 2026-2
**Character Count:** 8265
**Document Hash:** b2c4edf168fd0a1a000748478b7345d2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-021556.hdr.sgml**: 20260227

**ACCESSION NUMBER**: 0001213900-26-021556

**CONFORMED SUBMISSION TYPE**: S-8 POS

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260227

**DATE AS OF CHANGE**: 20260227

**EFFECTIVENESS DATE**: 20260227

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STRATA Skin Sciences, Inc.
- **CENTRAL INDEX KEY:** 0001051514
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 133986004
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8 POS
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-189119
- **FILM NUMBER:** 26699495

**BUSINESS ADDRESS:**
- **STREET 1:** 5 WALNUT GROVE DRIVE
- **STREET 2:** SUITE 140
- **CITY:** HORSHAM
- **STATE:** PA
- **ZIP:** 19044
- **BUSINESS PHONE:** 215-619-3200

**MAIL ADDRESS:**
- **STREET 1:** 5 WALNUT GROVE DRIVE
- **STREET 2:** SUITE 140
- **CITY:** HORSHAM
- **STATE:** PA
- **ZIP:** 19044

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MELA SCIENCES, INC. /NY
- **DATE OF NAME CHANGE:** 20100504

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ELECTRO OPTICAL SCIENCES INC /NY
- **DATE OF NAME CHANGE:** 19971216

**As filed with the U.S. Securities and Exchange Commission on February 27, 2026**

**Registration No. 333-257867**

**Registration No. 333-226298**

**Registration No. 333-216712**

**Registration No. 333-208397**

**Registration No. 333-189119**

**Registration No. 333-161286**

**Registration No. 333-136183**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-257867**

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-226298**

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-216712**

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-208397**

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-189119**

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-161286**

**POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-136183**

**UNDER THE SECURITIES ACT OF 1933**

**STRATA Skin Sciences, Inc.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **13-3986004** |
| (State or other jurisdiction<br> of incorporation) | (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **5 Walnut Grove Drive, Suite 140, Horsham, PA** | **19044** |
| (Address of principal executive offices) | (Zip Code) |

---

**STRATA Skin Sciences, Inc. 2016 Amended and Restated Omnibus Incentive Plan**

(Full title of the plan)

---

| | |
|:---|:---|
| Dr. Dolev Rafaeli | *Copies to:* |
| President and Chief Executive Officer | Joseph Wolfson |
| STRATA Skin Sciences, Inc. | Stevens & Lee, P.C. |
| 5 Walnut Grove Drive, Suite 140 | 1500 Market Street, East Tower |
| Horsham, PA 19044 | 18<sup>th</sup> Floor |
| (215) 619-3200 | Philadelphia, PA 19102 |
| (Name, address and telephone number, including area code, of agent for service) | (215) 575-0100 |

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ◻ Accelerated filer ◻ Non-accelerated filer ☒ <br> Smaller reporting company ☒ Emerging growth company ◻

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**This Registration Statement shall become effective upon filing in accordance with Rule 464 promulgated under the Securities Act of 1933, as amended.**

**DEREGISTRATION OF SHARES**

The class of securities to which this Registration Statement on Form S-8 (File No. 333-257867) (the "Registration Statement") relates is held by fewer than 300 shareholders of record. STRATA Skin Sciences, Inc. (the "Company") is filing this Post-Effective Amendment No. 1 to the Registration Statement to deregister all of the shares of common stock, $0.001 par value, of the Company, and related stock options therefor, registered under the Registration Statement that remain unissued under STRATA Skin Sciences, Inc. 2016 Amended and Restated Omnibus Incentive Plan.

This Post-Effective Amendment relates to the following Registration Statements on Form S-8 (collectively, the "Registration Statements") filed by STRATA Skin Sciences, Inc., a Delaware corporation (the "Company"), with the Securities and Exchange Commission:

● Registration No. [333-257867](https://www.sec.gov/Archives/edgar/data/1051514/000105151421000032/form_s-8.htm) , filed on July 13, 2021, registering 7,947,259 shares of common stock under the STRATA Skin Sciences, Inc. 2016 Amended and Restated Omnibus Incentive Plan.

● Registration No. [333-226298](https://www.sec.gov/Archives/edgar/data/1051514/000105151418000044/form-s-8.htm) , filed on July 23, 2018, registering 3,134,365 shares of common stock under the STRATA Skin Sciences, Inc. 2016 Omnibus Incentive Plan.

● Registration No. [333-216712](https://www.sec.gov/Archives/edgar/data/1051514/000105151417000018/form_s-8.htm) , filed on March 15, 2017, registering 10,565,648 shares of common stock under the STRATA Skin Sciences, Inc. 2016 Omnibus Incentive Plan.

● Registration No. [333-208397](https://www.sec.gov/Archives/edgar/data/1051514/000105151415000020/form_s-8.htm) , filed on December 9, 2015, registering 9,750,000 shares of common stock under the MELA Sciences, Inc. 2013 Stock Incentive Plan.

● Registration No. [333-189119](https://www.sec.gov/Archives/edgar/data/1051514/000119312513248787/d543225ds8.htm) , filed on June 5, 2013, registering 4,000,000 shares of common stock under the MELA Sciences, Inc. 2013 Stock Incentive Plan and the MELA Sciences, Inc. 2005 Stock Incentive Plan.

● Registration No. [333-161286](https://www.sec.gov/Archives/edgar/data/1051514/000095012309033975/y78767sv8.htm) , filed on August 12, 2009, registering 2,225,028 shares of common stock under the MELA Sciences, Inc. 2005 Stock Incentive Plan (f/k/a Electro-Optical Sciences, Inc. 2005 Stock Incentive Plan).

● Registration No. [333-136183](https://www.sec.gov/Archives/edgar/data/1051514/000095012306009655/y23579sv8.htm) , filed on July 31, 2006, registering 1,899,875 shares of common stock under the MELA Sciences, Inc. 2005 Stock Incentive Plan (f/k/a Electro-Optical Sciences, Inc. 2005 Stock Incentive Plan), the Electro-Optical Sciences, Inc. 2003 Stock Incentive Plan and the Electro-Optical Sciences, Inc. 1996 Stock Incentive Plan.

As previously disclosed, on February 11, 2026, the Board of Directors of the Company approved a plan to voluntarily delist the Company's common stock from The Nasdaq Capital Market, suspend its duty to file periodic reports and other information with the SEC, and terminate its registration of common stock under U.S. federal securities laws.

**SIGNATURES**

**The Registrant.** Pursuant to the requirements of the Securities Exchange Act of 1933, as amended, the Registrant certifies that is has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Horsham, Commonwealth of Pennsylvania, on February 27, 2026.

---

| | |
|:---|:---|
|  | STRATA SKIN SCIENCES, INC. |
| Date: February 27, 2026 | /s/ Dolev Rafaeli |
|  | Dolev Rafaeli |
|  | President and Chief Executive Officer |
|  | (Duly Authorized Representative) |

---

No other person is required to sign this Post-EffectiveAmendment in reliance upon Rule 478 under the SecuritiesAct of 1933, as amended.